Search Results - "Girijavallabhan, Viyyoor"
-
1
Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection
Published in Journal of medicinal chemistry (05-10-2006)“…Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, which affects more than 170…”
Get full text
Journal Article -
2
New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents
Published in Bioorganic & medicinal chemistry letters (15-02-2014)“…Tertiary hydroxyl class of C-imidazole bridgehead azaheptapyridine FPT inhibitors were prepared in an attempt to block in vivo oxidation of secondary hydroxyl…”
Get full text
Journal Article -
3
Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist
Published in Journal of medicinal chemistry (28-12-2006)“…Structure−activity studies on lead cyclobutenedione 3 led to the discovery of 4 (SCH 527123), a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist…”
Get full text
Journal Article -
4
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor
Published in ACS medicinal chemistry letters (13-05-2010)“…Boceprevir (SCH 503034), 1, a novel HCV NS3 serine protease inhibitor discovered in our laboratories, is currently undergoing phase III clinical trials…”
Get full text
Journal Article -
5
Potent inhibitors of HCV-NS3 protease derived from boronic acids
Published in Bioorganic & medicinal chemistry letters (01-01-2009)“…Chronic hepatitis C infection is the leading causes for cirrhosis of the liver and hepatocellular carcinoma, leading to liver failure and liver…”
Get full text
Journal Article -
6
The introduction of P4 substituted 1-methylcyclohexyl groups into Boceprevir®: A change in direction in the search for a second generation HCV NS3 protease inhibitor
Published in Bioorganic & medicinal chemistry letters (15-04-2010)“…In the search for a second generation HCV protease inhibitor, molecular modeling studies of the X-ray crystal structure of Boceprevir® 1 bound to the NS3…”
Get full text
Journal Article -
7
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and Wap-ras transgenic mice
Published in Cancer research (Chicago, Ill.) (01-11-1998)“…We have been developing a series of nonpeptidic, small molecule farnesyl protein transferase inhibitors that share a common tricyclic nucleus and compete with…”
Get full text
Journal Article -
8
Discovery of C-imidazole azaheptapyridine FPT inhibitors
Published in Bioorganic & medicinal chemistry letters (01-02-2010)“…The discovery of C-linked imidazole azaheptapyridine bridgehead FPT inhibitors is described. This novel class of compounds are sub nM FPT enzyme inhibitors…”
Get full text
Journal Article -
9
Design and Synthesis of Depeptidized Macrocyclic Inhibitors of Hepatitis C NS3-4A Protease Using Structure-Based Drug Design
Published in Journal of medicinal chemistry (11-08-2005)“…Hepatitus C virus (HCV) NS3, when bound to NS-4A cofactor, facilitates development of mature virons by catalyzing cleavage of a polyprotein to form functional…”
Get full text
Journal Article -
10
Enzymatic Kinetic Resolution of Piperidine Atropisomers: Synthesis of a Key Intermediate of the Farnesyl Protein Transferase Inhibitor, SCH66336
Published in Journal of organic chemistry (08-09-2000)“…The resolution of secondary amines via enzyme-catalyzed acylation is a relatively rare process. The kinetic resolution of a series of intermediates of SCH66336…”
Get full text
Journal Article -
11
Mass spectrometric studies of potent inhibitors of farnesyl protein transferase--detection of pentameric noncovalent complexes
Published in Journal of mass spectrometry. (01-10-2008)“…Farnesyl protein transferase (FPT) inhibition is an interesting and promising approach to noncytotoxic anticancer therapy. Research in this area has resulted…”
Get full text
Journal Article -
12
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 ( 1), and the discovery of posaconazole [Sch 56592; 2 or ( S, S)- 5]
Published in Bioorganic & medicinal chemistry letters (2006)“…As part of a detailed study, the syntheses, biological activities, and pharmacokinetic properties of hydroxylated analogues of the previously described broad…”
Get full text
Journal Article -
13
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide (SCH-66336): A Very Potent Farnesyl Protein Transferase Inhibitor as a Novel Antitumor Agent
Published in Journal of medicinal chemistry (19-11-1998)“…We have previously shown that appropriate modification of the benzocycloheptapyridine tricyclic ring system can provide potent farnesyl protein transferase…”
Get full text
Journal Article -
14
Tricyclic Farnesyl Protein Transferase Inhibitors: Crystallographic and Calorimetric Studies of Structure−Activity Relationships
Published in Journal of medicinal chemistry (17-06-1999)“…Crystallographic and thermodynamic studies of farnesyl protein transferase (FPT) complexed with novel tricyclic inhibitors provide insights into the observed…”
Get full text
Journal Article -
15
A Convenient Synthesis of Cis and Trans 4-tert-Butoxycarbonyl-Substituted Cyclohexylglycine
Published in Journal of organic chemistry (19-04-2002)“…A novel synthesis of cis and trans substituted 4-tert-butoxycarbonyl cyclohexylglycines via asymmetric aminohydroxylation of vinyl styrene followed by…”
Get full text
Journal Article -
16
Concise asymmetric routes to 2,2,4-trisubstituted tetrahydrofurans via chiral titanium imide enolates: Key intermediates towards synthesis of highly active azole antifungals SCH 51048 and SCH 56592
Published in Tetrahedron letters (05-08-1996)“…Two complimentary approaches to the key (−)-(2 R)-cis-tosylate 1 and its (+)-(2S)-enantiomer 15 via generation of chiral imide enolates having a…”
Get full text
Journal Article -
17
Interaction of a Novel GDP Exchange Inhibitor with the Ras Protein
Published in Biochemistry (Easton) (10-11-1998)“…Mutated, tumorigenic Ras is present in a variety of human tumors. Compounds that inhibit tumorigenic Ras function may be useful in the treatment of Ras-related…”
Get full text
Journal Article -
18
Synthesis and antifungal activity of the 2,2,5-tetrahydrofuran regioisomers of SCH 51048
Published in Bioorganic & medicinal chemistry letters (08-07-2002)“…The four 2,2,5-regioisomer counterparts of SCH 51048 were synthesized and evaluated. As with the parent series, only the two cis isomers possessed any in vitro…”
Get full text
Journal Article -
19
Identification of Pharmacokinetically Stable 3,10-Dibromo-8-chlorobenzocycloheptapyridine Farnesyl Protein Transferase Inhibitors with Potent Enzyme and Cellular Activities
Published in Journal of medicinal chemistry (15-07-1999)“…Farnesyl protein transferase (FPT) is a promising target for the development of cancer chemotherapeutics because it is responsible for the farnesylation of…”
Get full text
Journal Article -
20
Inhibitors of Farnesyl Protein Transferase. 4-Amido, 4-Carbamoyl, and 4-Carboxamido Derivatives of 1-(8-Chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-Bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine
Published in Journal of medicinal chemistry (12-03-1998)“…The synthesis of a variety of novel 4-amido, 4-carbamoyl and 4-carboxamido derivatives of…”
Get full text
Journal Article